{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:25Z","timestamp":1791357205480,"version":"4.3.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T00:00:00Z","timestamp":1169510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychol Rev"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11065-006-9017-3","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T16:34:27Z","timestamp":1169483667000},"page":"61-72","source":"Crossref","is-referenced-by-count":110,"title":["Pharmacologic Treatment of Attention-Deficit\/Hyperactivity Disorder: Efficacy, Safety and Mechanisms of Action"],"prefix":"10.1007","volume":"17","author":[{"given":"Steven R.","family":"Pliszka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"9017_CR1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.chi.0000155320.52322.37","volume":"44","author":"H. Abikoff","year":"2005","unstructured":"Abikoff, H., McGough, J., Vitiello, B., McCracken, J., Davies, M., Walkup, J., et\u00a0al. (2005). Sequential pharmacotherapy for children with comorbid attention-deficit\/hyperactivity and anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 418\u2013427.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","volume":"65","author":"A. J. Allen","year":"2005","unstructured":"Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., et\u00a0al. (2005). Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology, 65, 1941\u20131949.","journal-title":"Neurology"},{"key":"9017_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","volume":"14","author":"M. G. Aman","year":"2004","unstructured":"Aman, M. G., Binder, C., & Turgay, A. (2004). Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology, 14, 243\u2013254.","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"9017_CR4","volume-title":"ADHD and the nature of self control","author":"R. A. Barkley","year":"1997","unstructured":"Barkley, R. A. (1997). ADHD and the nature of self control. New York: Guildford Press."},{"key":"9017_CR5","first-page":"184","volume-title":"Attention Deficit Hyperactivity Disorder","author":"R. A. Barkley","year":"2006","unstructured":"Barkley, R. A. (2006). Comorbid disorders, social and family adjustment, and subtyping. In R. A. Barkley (Ed.), Attention Deficit Hyperactivity Disorder (pp. 184\u2013218). New York: Guilford Press."},{"key":"9017_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1388-2457(02)00362-0","volume":"114","author":"R. J. Barry","year":"2003","unstructured":"Barry, R. J., Clarke, A. R., & Johnstone, S. J. (2003). A review of electrophysiology in attention-deficit\/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clinical Neurophysiology, 114, 171\u2013183.","journal-title":"Clinical Neurophysiology"},{"key":"9017_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1388-2457(02)00363-2","volume":"114","author":"R. J. Barry","year":"2003","unstructured":"Barry, R. J., Johnstone, S. J., & Clarke, A. R. (2003). A review of electrophysiology in attention-deficit\/hyperactivity disorder: II. Event-related potentials. Clinical Neurophysiology, 114, 184\u2013198.","journal-title":"Clinical Neurophysiology"},{"key":"9017_CR8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.110.2.258","volume":"110","author":"J. Biederman","year":"2002","unstructured":"Biederman, J., Lopez, F. A., Boellner, S. W., & Chandler, M. C. (2002). A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit\/hyperactivity disorder. Pediatrics, 110, 258\u2013266.","journal-title":"Pediatrics"},{"key":"9017_CR9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","volume":"59","author":"J. Biederman","year":"2006","unstructured":"Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., et\u00a0al. (2006). A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biological Psychiatry, 59, 829\u2013835.","journal-title":"Biological Psychiatry"},{"key":"9017_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S1092852900019489","volume":"10","author":"J. Biederman","year":"2005","unstructured":"Biederman, J., Spencer, T. J., Wilens, T. E., Weisler, R. H., Read, S.\u2009C., & Tulloch, S. J. (2005). Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectrum, 10, 16\u201325.","journal-title":"CNS Spectrum"},{"key":"9017_CR11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clinthera.2006.02.008","volume":"28","author":"J. Biederman","year":"2006","unstructured":"Biederman, J., Wigal, S. B., Spencer, T. J., McGough, J. J., & Mays, D. A. (2006). A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit\/hyperactivity disorder. Clinical Therapeutics, 28, 280\u2013293.","journal-title":"Clinical Therapeutics"},{"key":"9017_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.94.3.577","volume":"94","author":"C. Bradley","year":"1937","unstructured":"Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577\u2013585.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpsycho.2005.03.008","volume":"58","author":"S. J. Broyd","year":"2005","unstructured":"Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz, M., et\u00a0al. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit\/hyperactivity disorder. International Journal of Psychophysiology, 58, 47\u201358.","journal-title":"International Journal of Psychophysiology"},{"key":"9017_CR14","unstructured":"Bush, G. (2005). Funcitional MRI: Recent advances in studying ADHD pathophysiology and treatment. Presented at the 52nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Toronto, CA (Oct. 18\u201323)."},{"key":"9017_CR15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0006-3223(99)00083-9","volume":"45","author":"G. Bush","year":"1999","unstructured":"Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., et\u00a0al. (1999). Anterior cingulate cortex dysfunction in attention-deficit\/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biological Psychiatry, 45, 1542\u20131552.","journal-title":"Biological Psychiatry"},{"key":"9017_CR16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.biopsych.2005.01.034","volume":"57","author":"G. Bush","year":"2005","unstructured":"Bush, G., Valera, E. M., & Seidman, L. J. (2005). Functional neuroimaging of attention-deficit\/hyperactivity disorder: A review and suggested future directions. Biological Psychiatry, 57, 1273\u20131284.","journal-title":"Biological Psychiatry"},{"key":"9017_CR17","first-page":"1630","volume":"43","author":"F. X. Castellanos","year":"2002","unstructured":"Castellanos, F. X. (2002). Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder. Journal of Nuclear Medicine, 43, 1630\u20131633.","journal-title":"Journal of Nuclear Medicine"},{"key":"9017_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.chi.0000199026.91699.20","volume":"45","author":"A. Charach","year":"2006","unstructured":"Charach, A., Figueroa, M., Chen, S., Ickowicz, A., & Schachar, R. (2006). Stimulant treatment over 5 years: Effects on growth. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 415\u2013421.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-002-1205-0","volume":"164","author":"A. R. Clarke","year":"2002","unstructured":"Clarke, A. R., Barry, R. J., Bond, D., McCarthy, R., & Selikowitz, M. (2002). Effects of stimulant medications on the EEG of children with attention-deficit\/hyperactivity disorder. Psychopharmacology (Berl.), 164, 277\u2013284.","journal-title":"Psychopharmacology (Berl.)"},{"key":"9017_CR20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/1469-8986.3820212","volume":"38","author":"A. R. Clarke","year":"2001","unstructured":"Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001). Electroencephalogram differences in two subtypes of attention-deficit\/hyperactivity disorder. Psychophysiology, 38, 212\u2013221.","journal-title":"Psychophysiology"},{"key":"9017_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1388-2457(01)00736-2","volume":"113","author":"A. R. Clarke","year":"2002","unstructured":"Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2002). EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit\/hyperactivity disorder. Clinical Neurophysiology, 113, 194\u2013205.","journal-title":"Clinical Neurophysiology"},{"key":"9017_CR22","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","volume":"35","author":"C. K. Conners","year":"1996","unstructured":"Conners, C. K., Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., et\u00a0al. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314\u20131321.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00004583-199912000-00017","volume":"38","author":"D. F. Connor","year":"1999","unstructured":"Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1551\u20131559.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","volume":"41","author":"D. F. Connor","year":"2002","unstructured":"Connor, D. F., Glatt, S. J., Lopez, I. D., Jackson, D., & Melloni, R. H., Jr. (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 253\u2013261.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","volume":"45","author":"C. U. Correll","year":"2006","unstructured":"Correll, C. U. & Carlson, H. E. (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 771\u2013791.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0031-3955(05)70065-1","volume":"45","author":"J. M. Daly","year":"1998","unstructured":"Daly, J. M., & Wilens, T. (1998). The use of tricyclics antidepressants in children and adolescents. Pediatric Clinics of North America, 45, 1123\u20131135.","journal-title":"Pediatric Clinics of North America"},{"key":"9017_CR27","unstructured":"Faraone, S. V., Biederman, J., Morley, C. P., & Spencer, T. J. (2006). The effect of stimulants on height and weight: a review of the literature (manuscript in preparation)."},{"key":"9017_CR28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pediatrneurol.2005.04.008","volume":"33","author":"F. J. Feron","year":"2005","unstructured":"Feron, F. J., Hendriksen, J. G., van Kroonenburgh, M. J., Blom-Coenjaerts, C., Kessels, A. G., Jolles, J., et\u00a0al. (2005). Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate. Pediatric Neurology, 33, 179\u2013183.","journal-title":"Pediatric Neurology"},{"key":"9017_CR29","unstructured":"Findling, R. L., & Lopez, F. A. (2005). Efficacy of transdermal methylphenidate with reference to Concerta in ADHD. Presented at the 25th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, CA, (Oct 18\u201323)."},{"key":"9017_CR30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jpeds.2005.03.014","volume":"147","author":"R. L. Findling","year":"2005","unstructured":"Findling, R. L., Biederman, J., Wilens, T. E., Spencer, T. J., McGough, J. J., Lopez, F. A., et\u00a0al. (2005). Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. The Journal of Pediatrics, 147, 348\u2013354.","journal-title":"The Journal of Pediatrics"},{"key":"9017_CR31","unstructured":"Food and Drug Administration (2005). FDA Alert [09\/05]: Suicidal thinking in children and adolescents. Available at. Food and Drug Administration Website [On-line]. Available: http:\/\/www.fda.gov\/cder\/drug\/infopage\/atomoxetine\/default.htm"},{"key":"9017_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","volume":"56","author":"K. D. Gadow","year":"1999","unstructured":"Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999). Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder [see comments]. Archives of General Psychiatry, 56, 330\u2013336.","journal-title":"Archives of General Psychiatry"},{"key":"9017_CR33","unstructured":"Gelperin, K. (2006). Psychiatric adverse events associated with drug treatment of ADHD: Review of post marketing safety data. Available at. Food and Drug Administration Website [On-line]. Available: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/briefing\/2006-4210B-Index.htm"},{"key":"9017_CR34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.chi.0000205709.63571.c9","volume":"45","author":"L. L. Greenhill","year":"2006","unstructured":"Greenhill, L. L., Biederman, J., Boellner, S. W., Rugino, T. A., Sangal, R. B., Earl, C. Q., et\u00a0al. (2006a). A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 503\u2013511.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR35","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.109.3.e39","volume":"109","author":"L. L. Greenhill","year":"2002","unstructured":"Greenhill, L. L., Findling, R. L., & Swanson, J. M. (2002). A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit\/hyperactivity disorder. Pediatrics, 109, E39.","journal-title":"Pediatrics"},{"key":"9017_CR36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.chi.0000220847.41027.5d","volume":"45","author":"L. L. Greenhill","year":"2006","unstructured":"Greenhill, L. L., Muniz, R., Ball, R. R., Levine, A., Pestreich, L., & Jiang, H. (2006b). Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit\/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 817\u2013823.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","volume":"63","author":"T. A. Hammad","year":"2006","unstructured":"Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332\u2013339.","journal-title":"Archives of General Psychiatry"},{"key":"9017_CR38","doi-asserted-by":"crossref","unstructured":"Jensen, P. S., Youngstrom, Y., Steiner, H., Findling, R. L., Meyer, R. E., Malone, R., et\u00a0al. (in press) Consensus report: Impulsive aggression as a symptom across diagnostic categories in child psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry.","DOI":"10.1097\/chi.0b013e31802f1454"},{"key":"9017_CR39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/1469-8986.3730334","volume":"37","author":"L. M. Jonkman","year":"2000","unstructured":"Jonkman, L. M., Kemner, C., Verbaten, M. N., van Engeland, H., Camfferman, G., Buitelaar, J. K., et\u00a0al. (2000). Attentional capacity, a probe ERP study: Differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate. Psychophysiology, 37, 334\u2013346.","journal-title":"Psychophysiology"},{"key":"9017_CR40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopsych.2004.11.009","volume":"57","author":"A. Jucaite","year":"2005","unstructured":"Jucaite, A., Fernell, E., Halldin, C., Forssberg, H., & Farde, L. (2005). Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit\/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biological Psychiatry, 57, 229\u2013238.","journal-title":"Biological Psychiatry"},{"key":"9017_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3349\/ymj.2001.42.1.19","volume":"42","author":"B. N. Kim","year":"2001","unstructured":"Kim, B. N., Lee, J. S., Cho, S. C., & Lee, D. S. (2001). Methylphenidate increased regional cerebral blood flow in subjects with attention deficit\/hyperactivity disorder. Yonsei Medical Journal, 42, 19\u201329.","journal-title":"Yonsei Medical Journal"},{"key":"9017_CR42","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.1997.01830240023003","volume":"54","author":"R. G. Klein","year":"1997","unstructured":"Klein, R. G., Abikoff, H., Klass, E., Ganeles, D., Seese, L. M., & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54, 1073\u20131080.","journal-title":"Archives of General Psychiatry"},{"key":"9017_CR43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/002221949102400301","volume":"24","author":"R. Klorman","year":"1991","unstructured":"Klorman, R. (1991). Cognitive event-related potentials in attention deficit disorder. Journal of Learning Disabilities, 24, 130\u2013140.","journal-title":"Journal of Learning Disabilities"},{"key":"9017_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0301-0511(86)90087-6","volume":"23","author":"A. Kok","year":"1986","unstructured":"Kok, A. (1986). Effects of degradation of visual stimuli on components of the event-related potential (ERP) in go\/nogo reaction tasks. Biological Psychology, 23, 21\u201338.","journal-title":"Biological Psychology"},{"key":"9017_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0511(96)05221-0","volume":"45","author":"A. Kok","year":"1997","unstructured":"Kok, A. (1997). Event-related-potential (ERP) reflections of mental resources: A review and synthesis. Biological Psychology, 45, 19\u201356.","journal-title":"Biological Psychology"},{"key":"9017_CR46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neubiorev.2003.08.012","volume":"27","author":"K. H. Krause","year":"2003","unstructured":"Krause, K. H., Dresel, S. H., Krause, J., la Fougere, C., & Ackenheil, M. (2003). The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 27, 605\u2013613.","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"9017_CR47","first-page":"1624","volume":"43","author":"D. D. Langleben","year":"2002","unstructured":"Langleben, D. D., Acton, P. D., Austin, G., Elman, I., Krikorian, G., Monterosso, J. R., et\u00a0al. (2002). Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. Journal of Nuclear Medicine, 43, 1624\u20131629.","journal-title":"Journal of Nuclear Medicine"},{"key":"9017_CR48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1207\/s15324826an1202_2","volume":"12","author":"S. K. Loo","year":"2005","unstructured":"Loo, S. K. & Barkley, R. A. (2005). Clinical utility of EEG in attention deficit hyperactivity disorder. Applied Neuropsychology, 12, 64\u201376.","journal-title":"Applied Neuropsychology"},{"key":"9017_CR49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.WNP.0000150890.14421.9A","volume":"21","author":"S. K. Loo","year":"2004","unstructured":"Loo, S. K., Hopfer, C., Teale, P. D., & Reite, M. L. (2004). EEG correlates of methylphenidate response in ADHD: Association with cognitive and behavioral measures. Journal of Clinical Neurophysiology, 21, 457\u2013464.","journal-title":"Journal of Clinical Neurophysiology"},{"key":"9017_CR50","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.CHI.0000046890.27264.88","volume":"42","author":"S. K. Loo","year":"2003","unstructured":"Loo, S. K., Specter, E., Smolen, A., Hopfer, C., Teale, P. D., & Reite, M. L. (2003). Functional effects of the DAT1 polymorphism on EEG measures in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 986\u2013993.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR51","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1176\/ajp.151.5.658","volume":"151","author":"J. A. Matochik","year":"1994","unstructured":"Matochik, J. A., Liebenauer, L. L., King, A. C., Szymanski, H. V., Cohen, R. M., & Zametkin, A. J. (1994). Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. American Journal of Psychiatry, 151, 658\u2013664.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.1993.38","volume":"8","author":"J. A. Matochik","year":"1993","unstructured":"Matochik, J. A., Nordahl, T. E., Gross, M., Semple, W. E., King, A. C., Cohen, R. M., et\u00a0al. (1993). Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology, 8, 377\u2013386.","journal-title":"Neuropsychopharmacology"},{"key":"9017_CR53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.chi.0000157550.94702.a2","volume":"44","author":"J. J. McGough","year":"2005","unstructured":"McGough, J. J., Biederman, J., Wigal, S. B., Lopez, F. A., McCracken, J. T., Spencer, T., et\u00a0al. (2005). Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 530\u2013538.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","volume":"53","author":"D. Michelson","year":"2003","unstructured":"Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., et\u00a0al. (2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112\u2013120.","journal-title":"Biological Psychiatry"},{"key":"9017_CR55","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","volume":"159","author":"D. Michelson","year":"2002","unstructured":"Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., et\u00a0al. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896\u20131901.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D. Michelson","year":"2001","unstructured":"Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, R., et\u00a0al. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics, 108, 1\u20139.","journal-title":"Pediatrics"},{"key":"9017_CR57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.113.4.762","volume":"113","author":"MTA Cooperative Group","year":"2004","unstructured":"MTA Cooperative Group (2004). National institute of mental health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762\u2013769.","journal-title":"Pediatrics"},{"key":"9017_CR58","unstructured":"MTA Cooperative Group (2006). Effects of stimulant medication on growth rates across three years in the MTA follow up. (in submission)."},{"key":"9017_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-005-0078-4","volume":"182","author":"U. Muller","year":"2005","unstructured":"Muller, U., Clark, L., Lam, M. L., Moore, R. M., Murphy, C. L., Richmond, N. K., et\u00a0al. (2005). Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology (Berl.), 182, 205\u2013213.","journal-title":"Psychopharmacology (Berl.)"},{"key":"9017_CR60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","volume":"44","author":"J. H. Newcorn","year":"2005","unstructured":"Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005). Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 240\u2013248.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004583-200302000-00008","volume":"42","author":"E. Pappadopulos","year":"2003","unstructured":"Pappadopulos, E., Macintyre Ii, J. C., Crismon, M. L., Findling, R. L., Malone, R. P., Derivan, A., et\u00a0al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 145\u2013161.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00004583-200005000-00016","volume":"39","author":"S. R. Pliszka","year":"2000","unstructured":"Pliszka, S. R., Browne, R., Olvera, R. L., & Wynne, S. K. (2000). A double-blind placebo controlled trial of Adderall and methylphendiate in the treatment of Attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 619\u2013626.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR63","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","volume":"45","author":"S. R. Pliszka","year":"2006","unstructured":"Pliszka, S. R., Crismon, M. L., Hughes, C. W., Corners, C. K., Emslie, G. J., Jensen, P. S., et\u00a0al. (2006a). The Texas Children\u2019s Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 642\u2013657.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR64","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1176\/ajp.2006.163.6.1052","volume":"163","author":"S. R. Pliszka","year":"2006","unstructured":"Pliszka, S. R., Glahn, D. C., Semrud-Clikeman, M., Franklin, C., Perez, R., Xiong, J., et\u00a0al. (2006b). Neuroimaging of inhibitory control areas in children with attention defict hyperactivity disorder who were treatment naive or in long term treatment. American Journal of Psychiatry, 163, 1052\u20131060.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-3223(00)00890-8","volume":"48","author":"S. R. Pliszka","year":"2000","unstructured":"Pliszka, S. R., Liotti, M., & Woldorff, M. G. (2000). Inhibitory control in children with attention deficit\/hyperactivity disorder: Event related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biological Psychiatry, 48, 238\u2013246.","journal-title":"Biological Psychiatry"},{"key":"9017_CR66","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.chi.0000205702.48324.fd","volume":"45","author":"S. R. Pliszka","year":"2006","unstructured":"Pliszka, S. R., Matthews, T. L., Braslow, K. J., & Watson, M. A. (2006c). Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit\/hyperactivity disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry, 45, 520\u2013526.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR67","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/adc.2004.056952","volume":"90","author":"A. Poulton","year":"2005","unstructured":"Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: A review. Archives of Diseases of Childhood, 90, 801\u2013806.","journal-title":"Archives of Diseases of Childhood"},{"key":"9017_CR68","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neuroimage.2004.11.031","volume":"25","author":"P. Rosa-Neto","year":"2005","unstructured":"Rosa-Neto, P., Lou, H. C., Cumming, P., Pryds, O., Karrebaek, H., Lunding, J., et\u00a0al. (2005). Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage, 25, 868\u2013876.","journal-title":"Neuroimage"},{"key":"9017_CR69","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.162.6.1067","volume":"162","author":"K. Rubia","year":"2005","unstructured":"Rubia, K., Smith, A. B., Brammer, M. J., Toone, B., & Taylor, E. (2005). Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. American Journal of Psychiatry, 162, 1067\u20131075.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR70","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"L. Scahill","year":"2001","unstructured":"Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., et\u00a0al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158, 1067\u20131074.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR71","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuropsychologia.2005.06.005","volume":"44","author":"M. Schmajuk","year":"2006","unstructured":"Schmajuk, M., Liotti, M., Busse, L., & Woldorff, M. G. (2006). Electrophysiological activity underlying inhibitory control processes in normal adults. Neuropsychologia., 44, 384\u2013395.","journal-title":"Neuropsychologia."},{"key":"9017_CR72","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004583-200302000-00007","volume":"42","author":"S. B. Schur","year":"2003","unstructured":"Schur, S. B., Sikich, L., Findling, R. L., Malone, R. P., Crismon, M. L., Derivan, A., et\u00a0al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 132\u2013144.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR73","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.npp.1300110","volume":"28","author":"J. B. Schweitzer","year":"2003","unstructured":"Schweitzer, J. B., Lee, D. O., Hanford, R. B., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., et\u00a0al. (2003). A positron emission tomography study of methylphenidate in adults with ADHD: Alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology, 28, 967\u2013973.","journal-title":"Neuropsychopharmacology"},{"key":"9017_CR74","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-003-0818-8","volume":"110","author":"J. Seifert","year":"2003","unstructured":"Seifert, J., Scheuerpflug, P., Zillessen, K. E., Fallgatter, A., & Warnke, A. (2003). Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. Journal of Neural Transmission, 110, 821\u2013829.","journal-title":"Journal of Neural Transmission"},{"key":"9017_CR75","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1176\/appi.ajp.161.11.1990","volume":"161","author":"K. M. Shafritz","year":"2004","unstructured":"Shafritz, K. M., Marchione, K. E., Gore, J. C., Shaywitz, S. E., & Shaywitz, B. A. (2004). The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. American Journal of Psychiatry, 161, 1990\u20131997.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR76","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","volume":"41","author":"R. Snyder","year":"2002","unstructured":"Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., & Carroll, A. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1026\u20131036.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","volume":"35","author":"T. Spencer","year":"1996","unstructured":"Spencer, T., Biederman, J., Wilens, T., Harding, M., O\u2019Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409\u2013432.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR78","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","volume":"57","author":"T. J. Spencer","year":"2005","unstructured":"Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., et\u00a0al. (2005). In vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: A focus on the dopamine transporter. Biological Psychiatry, 57, 1293\u20131300.","journal-title":"Biological Psychiatry"},{"key":"9017_CR79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.chi.0000205710.01690.d4","volume":"45","author":"T. J. Spencer","year":"2006","unstructured":"Spencer, T. J., Faraone, S. V., Biederman, J., Lerner, M., Cooper, K. M., & Zimmerman, B. (2006a). Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? Journal of the American Academy of Child and Adolescent Psychiatry, 45, 527\u2013537.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clinthera.2006.02.011","volume":"28","author":"T. J. Spencer","year":"2006","unstructured":"Spencer, T. J., Wilens, T. E., Biederman, J., Weisler, R. H., Read, S. C., & Pratt, R. (2006b). Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit\/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics, 28, 266\u2013279.","journal-title":"Clinical Therapeutics"},{"key":"9017_CR81","unstructured":"Sumner, C. S., Donnelly, C., Lopez, F. A., Sutton, V., Bakken, R., Paczkowski, M., et\u00a0al. (2005). Atomoxetine treatment for pediatric patients with ADHD and comorbid anxiety. Presented at the annual meeting of the American Psychiatric Association, Altanta, GA (May)."},{"key":"9017_CR82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4088\/JCP.v67n0120","volume":"67","author":"J. M. Swanson","year":"2006","unstructured":"Swanson, J. M., Greenhill, L. L., Lopez, F. A., Sedillo, A., Earl, C.\u2009Q., Jiang, J. G., et\u00a0al. (2006). Modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: Results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. Journal of Clinical Psychiatry, 67, 137\u2013147.","journal-title":"Journal of Clinical Psychiatry"},{"key":"9017_CR83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/001440299306000209","volume":"60","author":"J. M. Swanson","year":"1993","unstructured":"Swanson, J. M., McBurnett, K., Wigal, T., Pfiffner, L. J., Lerner, M. A., Williams, L., et\u00a0al. (1993). Effect of stimulant medication on children with attention deficit disorder: A \u201creview of reviews.\u201dExceptional Children, 60, 154\u2013162.","journal-title":"Exceptional Children"},{"key":"9017_CR84","unstructured":"Swensen, A., Michelsen, D., Buesching, D., & Faries, D. E. (2001). Effects of atomoxetine on social and family functioning of ADHD children and adolescents. Presented at the 48th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu,HI, (Oct 23\u201328)."},{"key":"9017_CR85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00259-002-1082-0","volume":"30","author":"C. M. Szobot","year":"2003","unstructured":"Szobot, C. M., Ketzer, C., Cunha, R. D., Parente, M. A., Langleben, D. D., Acton, P. D., et\u00a0al. (2003). The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit\/hyperactivity disorder. European Journal of Nuclear Medicine and Molecular Imaging, 30, 423\u2013426.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"9017_CR86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"Tourette\u2019s Syndrome Study Group","year":"2002","unstructured":"Tourette\u2019s Syndrome Study Group (2002). Treatment of ADHD in children with tics: A randomized controlled trial. Neurology, 58, 527\u2013536.","journal-title":"Neurology"},{"key":"9017_CR87","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1073\/pnas.95.24.14494","volume":"95","author":"C. J. Vaidya","year":"1998","unstructured":"Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., et\u00a0al. (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proceedings of the National Academy of Science, 95, 14494\u201314499.","journal-title":"Proceedings of the National Academy of Science"},{"key":"9017_CR88","unstructured":"Villalaba, L. (2006). Follow up review of AERS search identifying cases of sudden death occuring with drugs used for the treatment of attention deficit hyperactivity disorder (ADHD). Available at. Food and Drug Administration Website [On-line]. Available: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/briefing\/2006-4210B-Index.htm"},{"key":"9017_CR89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2003-39602","volume":"34","author":"J. S. Vles","year":"2003","unstructured":"Vles, J. S., Feron, F. J., Hendriksen, J. G., Jolles, J., van Kroonenburgh, M. J., & Weber, W. E. (2003). Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropediatrics., 34, 77\u201380.","journal-title":"Neuropediatrics."},{"key":"9017_CR90","doi-asserted-by":"crossref","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","volume":"21","author":"N. D. Volkow","year":"2001","unstructured":"Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., et\u00a0al. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, RC121.","journal-title":"Journal of Neuroscience"},{"key":"9017_CR91","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.biopsych.2004.11.006","volume":"57","author":"N. D. Volkow","year":"2005","unstructured":"Volkow, N. D., Wang, G. J., Fowler, J. S., & Ding, Y. S. (2005). Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for attention-deficit\/hyperactivity disorder. Biological Psychiatry, 57, 1410\u20131415.","journal-title":"Biological Psychiatry"},{"key":"9017_CR92","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","volume":"155","author":"N. D. Volkow","year":"1998","unstructured":"Volkow, N. D., Wang, G. J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y. S., et\u00a0al. (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry, 155, 1325\u20131331.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR93","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1176\/appi.ajp.161.7.1173","volume":"161","author":"N. D. Volkow","year":"2004","unstructured":"Volkow, N. D., Wang, G. J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., et\u00a0al. (2004). Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry, 161, 1173\u20131180.","journal-title":"American Journal of Psychiatry"},{"key":"9017_CR94","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900013687","volume":"11","author":"R. H. Weisler","year":"2006","unstructured":"Weisler, R. H., Biederman, J., Spencer, T. J., Wilens, T. E., Faraone, S. V., Chrisman, A. K., et\u00a0al. (2006). Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized, controlled trial. CNS Spectrum, 11, 625\u2013639.","journal-title":"CNS Spectrum"},{"key":"9017_CR95","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/01.chi.0000138352.06229.b0","volume":"43","author":"M. Weiss","year":"2004","unstructured":"Weiss, M., Wasdell, M., & Patin, J. (2004). A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin). Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1415\u20131421.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1087054705281121","volume":"9","author":"S. B. Wigal","year":"2005","unstructured":"Wigal, S. B., McGough, J. J., McCracken, J. T., Biederman, J., Spencer, T. J., Posner, K. L., et\u00a0al. (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit\/hyperactivity disorder. Journal of Attention Disorders, 9, 275\u2013289.","journal-title":"Journal of Attention Disorders"},{"key":"9017_CR97","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.chi.0000173291.28688.e7","volume":"44","author":"T. Wilens","year":"2005","unstructured":"Wilens, T., McBurnett, K., Stein, M., Lerner, M., Spencer, T., & Wolraich, M. (2005). ADHD treatment with once daily OROS methylphendiate treatment: Final results from a long term open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1015\u20131023.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"9017_CR98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpedi.160.1.82","volume":"160","author":"T. E. Wilens","year":"2006","unstructured":"Wilens, T. E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., Lerner, M., et\u00a0al. (2006). Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit\/hyperactivity disorder. Archives of Pediatrics and Adolescent Medicine, 160, 82\u201390.","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"9017_CR99","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.108.4.883","volume":"108","author":"M. L. Wolraich","year":"2001","unstructured":"Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., et\u00a0al. (2001). Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit\/hyperactivity disorder. Pediatrics, 108, 883\u2013892.","journal-title":"Pediatrics"}],"container-title":["Neuropsychology Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11065-006-9017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11065-006-9017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11065-006-9017-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T20:52:02Z","timestamp":1587329522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11065-006-9017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9017"],"URL":"https:\/\/doi.org\/10.1007\/s11065-006-9017-3","relation":{},"ISSN":["1040-7308","1573-6660"],"issn-type":[{"value":"1040-7308","type":"print"},{"value":"1573-6660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}